Clinical worsening in reversible cerebral vasoconstriction syndrome
- PMID: 24190097
- DOI: 10.1001/jamaneurol.2013.4639
Clinical worsening in reversible cerebral vasoconstriction syndrome
Abstract
Importance: Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by recurrent thunderclap headaches and evidence of vasoconstriction with subsequent resolution. The clinical course of RCVS is traditionally considered monophasic and benign. However, recurrent episodes of focal neurological symptoms have been described after initial presentation.
Objective: To define the frequency, timing, and consequences of clinical worsening in patients with diagnosis of RCVS.
Design, setting, and participants: Retrospective observational study of consecutive patients with RCVS at 2 referral institutions for neurological disease.
Main outcome and measure: Clinical worsening after diagnosis of RCVS. We defined clinical worsening as new permanent or transient neurological deficits (compared with presenting signs and symptoms) or new onset of seizures. We performed a logistic regression analysis to assess associations between patient characteristics and clinical worsening. Functional outcome was assessed at 1 to 3 months using the modified Rankin score.
Results: We identified 59 patients (median age, 47 years; interquartile range, 32-54 years) with RCVS. Twenty patients (34%) experienced clinical worsening after a median of 2.5 days (range, several hours to 14 days). Eight of the 20 patients who worsened had permanent deficits, including 4 who died. We did not find an association between age, sex, smoking, migraine, acute or chronic hypertension, peripartum state, or use of serotonergic drugs with clinical worsening. Clinical worsening was associated with radiological infarction (P = .001) and worse functional outcome (P < .004). Functional outcome was favorable (modified Rankin score 0-2) in 51 patients (86.4%).
Conclusions and relevance: Clinical worsening after diagnosis is common in patients with RCVS. Thus, RCVS is self-limited but not strictly monophasic. Most patients have a very favorable outcome, but clinical worsening may result in permanent deficits.
Comment in
-
Reversible cerebral vasoconstriction syndrome.JAMA Neurol. 2014 Mar;71(3):368. doi: 10.1001/jamaneurol.2013.5875. JAMA Neurol. 2014. PMID: 24614989 No abstract available.
-
Reversible cerebral vasoconstriction syndrome--reply.JAMA Neurol. 2014 Mar;71(3):368-9. doi: 10.1001/jamaneurol.2013.5899. JAMA Neurol. 2014. PMID: 24614990 No abstract available.
Similar articles
-
Narrative Review: Headaches After Reversible Cerebral Vasoconstriction Syndrome.Curr Pain Headache Rep. 2020 Nov 8;24(12):74. doi: 10.1007/s11916-020-00908-1. Curr Pain Headache Rep. 2020. PMID: 33161482 Review.
-
Reversible cerebral vasoconstriction syndrome identification of prognostic factors.Clin Neurol Neurosurg. 2013 Nov;115(11):2351-7. doi: 10.1016/j.clineuro.2013.08.014. Epub 2013 Sep 7. Clin Neurol Neurosurg. 2013. PMID: 24021453
-
Reversible cerebral vasoconstriction syndrome or primary angiitis of the central nervous system?Can J Neurol Sci. 2007 Nov;34(4):467-77. Can J Neurol Sci. 2007. PMID: 18062458
-
Recurrence of reversible cerebral vasoconstriction syndrome: a long-term follow-up study.Neurology. 2015 Apr 14;84(15):1552-8. doi: 10.1212/WNL.0000000000001473. Epub 2015 Mar 18. Neurology. 2015. PMID: 25788554
-
Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache.Headache. 2016 Apr;56(4):674-87. doi: 10.1111/head.12794. Epub 2016 Mar 26. Headache. 2016. PMID: 27016378 Review.
Cited by
-
Headache Attributed to Reversible Cerebral Vasoconstriction Syndrome (RCVS).Diagnostics (Basel). 2023 Aug 22;13(17):2730. doi: 10.3390/diagnostics13172730. Diagnostics (Basel). 2023. PMID: 37685270 Free PMC article. Review.
-
Reversible cerebral Vasoconstriction syndrome intERnational CollaborativE (REVERCE) network: Study protocol and rationale of a multicentre research collaboration.Eur Stroke J. 2023 Dec;8(4):1107-1113. doi: 10.1177/23969873231182207. Epub 2023 Jun 17. Eur Stroke J. 2023. PMID: 37329287 Free PMC article.
-
Advances in Management of the Stroke Etiology One-Percenters.Curr Neurol Neurosci Rep. 2023 Jun;23(6):301-325. doi: 10.1007/s11910-023-01269-z. Epub 2023 May 29. Curr Neurol Neurosci Rep. 2023. PMID: 37247169 Free PMC article. Review.
-
Neurological Complications in Pregnancy and the Puerperium: Methodology for a Clinical Diagnosis.J Clin Med. 2023 Apr 20;12(8):2994. doi: 10.3390/jcm12082994. J Clin Med. 2023. PMID: 37109329 Free PMC article. Review.
-
Complications of reversible cerebral vasoconstriction syndrome in relation to age.J Neurol. 2023 Jul;270(7):3584-3594. doi: 10.1007/s00415-023-11708-z. Epub 2023 Apr 13. J Neurol. 2023. PMID: 37052670 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
